Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?

Entsar Eladl, Hong Chang

Blood (2021) 137 (9): 1268.

https://doi.org/10.1182/blood.2020009735

Published: 2021

Journal Articles

Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

Ali Unal, MD, Serhat Çelik, Zeynep Güven, MD, Leylagul Kaynar, MD, Bulent Eser, MD, Mustafa Çetin

Blood (2019) 134 (Supplement_1): 5359.

https://doi.org/10.1182/blood-2019-123387

Published: 2019

Journal Articles

Plasmablastic Lymphoma in a Community-Based Cancer Center: A 10-Year Analysis of This Rare Disease in a Underserved Urban Area

Vinicius Machado Jorge, MD, Andrew Tiu, MD, Sorab Gupta, MD, Claudia Dourado, MD, Gabor Varadi, MD

Blood (2019) 134 (Supplement_1): 5361.

https://doi.org/10.1182/blood-2019-131905

Published: 2019

Journal Articles

Gastrointestinal (GI) Involvement with Non-Hodgkin's Lymphoma (NHL) Impacts Outcome; A Retrospective Single Tertiary Care Center Analysis of Clinico-Pathologic Characteristics Provides an Alternate Insight to Presentation and Outcome

Ghada Zakout, FRCPATH, MRCP (UK), MBBCh (Hon), Charalampia Kyriakou

Blood (2019) 134 (Supplement_1): 5246.

https://doi.org/10.1182/blood-2019-127152

Published: 2019

Journal Articles

Liquid Biopsy Is Useful to Identify the Genetic Profile of NHL-B at Diagnosis in Different Histological Subtypes

Mariana Bastos-Oreiro, MD PhD, Julia Suárez González, Natalia Carolina Carrión, Cristina Andres, Solsireey Moreno, Diego Carbonell, Mr, María Chicano Lavilla, PhD, Gillen Oarbeascoa, MD, Francisco Diaz Crespo, Javier Menarguez, MD PhD, José Luis Díez-Martín, MD PhD, Ismael Buño, PhD, Carolina Martínez-Laperche

Blood (2019) 134 (Supplement_1): 5216.

https://doi.org/10.1182/blood-2019-129868

Published: 2019

Journal Articles

Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-R

Vania Phuoc, MD, Leidy Isenalumhe, MD, Hayder Saeed, MD, Celeste Bello, MD, Bijal Shah, MD, Lubomir Sokol, MD PhD, Julio Chavez

Blood (2019) 134 (Supplement_1): 2898.

https://doi.org/10.1182/blood-2019-122393

Published: 2019

Journal Articles

Impact of Co-Morbidities on Outcome in a Predominantly Hispanic Population of Hodgkin and Non-Hodgkin Lymphoma Patients

Michelle Janania Martinez, MD, Juan F Garza, MD, Tyler W Snedden, MD, Prathibha Surapaneni, MD, Snegha Ananth, MBBS, Jeremy Rawlings, MD, David J Gregorio, DO, Sushanth Kakarla, MD, Qianqian Liu, PhD, Joel E Michalek, PhD, Adolfo Enrique Diaz, MD

Blood (2019) 134 (Supplement_1): 2204.

https://doi.org/10.1182/blood-2019-129442

Published: 2019

Journal Articles

The Changing Face of B-Cell Lymphoma in the Anti-Retroviral Therapy Era in South Africa

Tracey Monica Wiggill, MD MBBS, Elizabeth Sarah Mayne, MBBCh, FC Path(SA) Haem, MMed (Haem), Yvonne Perner, MBBCh, FC Path(SA) Anat, MMed (Anat), Jenifer Vaughan, MBBCh, FC Path(SA) Haem, MMed (Haem)

Blood (2019) 134 (Supplement_1): 3418.

https://doi.org/10.1182/blood-2019-126961

Published: 2019

Journal Articles

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Juan Carlos Ramos, MD BS, Joseph Sparano, MD, Page C. Moore, PhD, Eric Siegel, Jeannette Y Lee, PhD, Erin G. Reid, MD MS, Richard F. Ambinder, MD, Amy Chadburn, MD, Paul G. Rubinstein, MD, Christine Durand, Ethel Cesarman, MD PhD, Lee Ratner, MD PhD, Robert A Baiocchi, MD PhD, David M. Aboulafia, MD, Lawrence D Kaplan, MD, Adam Capoferri, Ronald T. Mitsuyasu, MD, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1588.

https://doi.org/10.1182/blood-2019-129687

Published: 2019

Journal Articles

A Multicenter, Open-Label Feasibility Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105

Carlyn Rose Tan, MD, Stefan K. Barta, MD MRCP, MS, Shelly Y. Lensing, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1595.

https://doi.org/10.1182/blood-2019-129702

Published: 2019

Journal Articles

Plasmablastic Lymphoma - Experience with Infusional EPOCH Chemotherapy from India

Jayachandran PK, MD MRCP, DM, Arun Kumar Rajan, MD DM, Nikita Mehra, MD DM, Gangothri Selvarajan, MD DM, Joshi Archit Girishchandra, MD DM, Parathan Karunakaran, MD DM, Manikandan Dhanushkodi, MD DM, Venkatraman Radhakrishnan, MD DM, Krishnarathinam Kannan, MD DM, Trivadi S Ganesan, MD FRCP, PhD, Tenali Gnana Sagar, MD DM

Blood (2019) 134 (Supplement_1): 5351.

https://doi.org/10.1182/blood-2019-127158

Published: 2019

Journal Articles

The Analysis of HIV-Associated Lymphoma in Japan

Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD, Junji Tanaka, MD PhD, Seiji Okada, MD PhD

Blood (2018) 132 (Supplement 1): 5315.

https://doi.org/10.1182/blood-2018-99-114060

Published: 2018

Journal Articles

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Thomas M. Habermann, MD, Angelo Fama, MD, Kay M. Ristow, BS, Matthew J. Maurer, MS, William R. Macon, MD, Stephen M. Ansell, MD PhD, Nabila Nora Bennani, MD, Yogish C Kudva, MBBS, Randall C. Walker, MD, Kimberly D. Watt, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 456.

https://doi.org/10.1182/blood-2018-99-113667

Published: 2018

Journal Articles

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

Agathe Pruvot Debliquis, pharmD, Lucile Baseggio, MD, Marie-Christine Jacob, Sabrina Bouyer, Franck Genevieve, MD PhD, Julien Guy, MD, Caroline Mayeur-Rousse, MD, Nicolas Chapuis, PharmD, PhD, Hind Bennani, Thomas Matthes, MD, Bernard Drenou

Blood (2018) 132 (Supplement 1): 2869.

https://doi.org/10.1182/blood-2018-99-115990

Published: 2018

Journal Articles

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy Project (CHAMP) Study

Camille E. Demarco, MPH, Pei Lu, MD, David F. Peace, Sunny Singh, MD, Dennis F. Angelov, Kelly A. Benante, MPH, Ahmed T. Ahmed, MD, Paul G. Rubinstein, MD

Blood (2018) 132 (Supplement 1): 2304.

https://doi.org/10.1182/blood-2018-99-117391

Published: 2018

Journal Articles

Molecular Characterization of Post-Transplant Plasmablastic Lymphomas Implicates RAS , TP53 , and NOTCH Mutations and MYC Deregulation in Disease Pathogenesis

Rebecca J Leeman-Neill, MDPhD, Patricia M. Raciti, MD, Susan J Hsiao, MD PhD, Murty Vundavalli, PhD, Bachir Alobeid, MD, Mahesh M Mansukhani, MD, Govind Bhagat, MD

Blood (2017) 130 (Supplement 1): 4014.

https://doi.org/10.1182/blood.V130.Suppl_1.4014.4014

Published: 2017

Journal Articles

Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders

Michihide Tokuhira, MD, Shuntaro Saito, MD, Ayumi Okuyama, MD, Katsuya Suzuki, MD, Morihiro Higashi, MD, Shuju Momose, MD, Takayuki Shimizu, MD, Takehiko Mori, MD PhD, Tomoe Anan-Nemoto, MD, Koichi Amano, MD, Shinichiro Okamoto, MD PhD, Tsutomu Takeuchi, MD, Jun-ichi Tamaru, MDPhD, Masahiro Kizaki, MDPhD

Blood (2017) 130 (Supplement 1): 4024.

https://doi.org/10.1182/blood.V130.Suppl_1.4024.4024

Published: 2017

Journal Articles

Outcomes and Risks of Allogeneic Hematopoietic Stem Cell Transplant for Hematological Malignancies in Patients with HIV Infection

Shukaib Arslan, MD, Nathan W. Cummins, MD, Stacey A. Rizza, MD, Andrew D. Badley, MD, Mark R. Litzow, MD, Willis H. Navarro, MD, Shahrukh K. Hashmi, MDMPH

Blood (2017) 130 (Supplement 1): 4596.

https://doi.org/10.1182/blood.V130.Suppl_1.4596.4596

Published: 2017

Journal Articles

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Annalisa Peli, MD, Nicola Bianchetti, MD, Angela Passi, MD, Emanuele Focà, MD, Maria Miscio, Francesco Castelli, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 5223.

https://doi.org/10.1182/blood.V130.Suppl_1.5223.5223

Published: 2017

Journal Articles

Insurance Status Impacts Survival in Burkitt Lymphoma

Jordan S. Goldstein, BS, Jeffrey M. Switchenko, PhD MS, Madhusmita Behera, PhD, Christopher Flowers, MD, Jean L. Koff, MD

Blood (2017) 130 (Supplement 1): 916.

https://doi.org/10.1182/blood.V130.Suppl_1.916.916

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?

Gastrointestinal Plasmoblastic Lymphoma Associated with Wiskott-Aldrich Syndrome: A Case Report

Plasmablastic Lymphoma in a Community-Based Cancer Center: A 10-Year Analysis of This Rare Disease in a Underserved Urban Area

Gastrointestinal (GI) Involvement with Non-Hodgkin's Lymphoma (NHL) Impacts Outcome; A Retrospective Single Tertiary Care Center Analysis of Clinico-Pathologic Characteristics Provides an Alternate Insight to Presentation and Outcome

Liquid Biopsy Is Useful to Identify the Genetic Profile of NHL-B at Diagnosis in Different Histological Subtypes

Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-R

Impact of Co-Morbidities on Outcome in a Predominantly Hispanic Population of Hodgkin and Non-Hodgkin Lymphoma Patients

The Changing Face of B-Cell Lymphoma in the Anti-Retroviral Therapy Era in South Africa

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

A Multicenter, Open-Label Feasibility Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105

Plasmablastic Lymphoma - Experience with Infusional EPOCH Chemotherapy from India

The Analysis of HIV-Associated Lymphoma in Japan

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy Project (CHAMP) Study

Molecular Characterization of Post-Transplant Plasmablastic Lymphomas Implicates RAS , TP53 , and NOTCH Mutations and MYC Deregulation in Disease Pathogenesis

Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders

Outcomes and Risks of Allogeneic Hematopoietic Stem Cell Transplant for Hematological Malignancies in Patients with HIV Infection

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Insurance Status Impacts Survival in Burkitt Lymphoma

Email alerts

ASH Publications

American Society of Hematology